Jon P. Stonehouse - Mar 21, 2023 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
President & CEO, Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Mar 21, 2023
Transactions value $
$99,997
Form type
4
Date filed
3/23/2023, 04:40 PM
Previous filing
Feb 2, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Options Exercise $100K +31.1K +3.08% $3.22 1.04M Mar 21, 2023 Direct F1
holding BCRX Common Stock 10K Mar 21, 2023 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
holding BCRX Common Stock 10K Mar 21, 2023 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -31.1K -9.21% $0.00 306K Mar 21, 2023 Common Stock 31.1K $3.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person engaged in a non-market, cash exercise and hold transaction to purchase shares of issuer common stock underlying stock options that were originally granted to the reporting person on May 23, 2016. No sales of the issuer's common stock have occurred as part of this transaction.